Vanda Pharmaceuticals (VNDA) Assets Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.41% |
| Dec 31, 2025 | -1.73% |
| Sep 30, 2025 | 3.11% |
| Jun 30, 2025 | 4.28% |
| Mar 31, 2025 | 5.28% |
| Dec 31, 2024 | 6.29% |
| Sep 30, 2024 | 6.34% |
| Jun 30, 2024 | 11.83% |
| Mar 31, 2024 | 13.20% |
| Dec 31, 2023 | 14.32% |
| Sep 30, 2023 | 15.52% |
| Jun 30, 2023 | 16.20% |
| Mar 31, 2023 | 15.23% |
| Dec 31, 2022 | 25.29% |
| Sep 30, 2022 | 24.76% |
| Jun 30, 2022 | 23.66% |
| Mar 31, 2022 | 24.14% |
| Dec 31, 2021 | 23.06% |
| Sep 30, 2021 | 22.70% |
| Jun 30, 2021 | 22.95% |
| Mar 31, 2021 | 21.31% |
| Dec 31, 2020 | 20.15% |
| Sep 30, 2020 | 18.53% |
| Jun 30, 2020 | 17.76% |
| Mar 31, 2020 | 17.99% |
| Dec 31, 2019 | 23.02% |
| Sep 30, 2019 | 43.06% |
| Jun 30, 2019 | 34.01% |
| Mar 31, 2019 | 23.75% |
| Dec 31, 2018 | 18.30% |
| Sep 30, 2018 | 15.00% |
| Jun 30, 2018 | 20.97% |
| Mar 31, 2018 | 20.45% |
| Dec 31, 2017 | 8.69% |
| Sep 30, 2017 | 6.55% |
| Jun 30, 2017 | 5.55% |
| Mar 31, 2017 | 3.47% |
| Dec 31, 2016 | 2.87% |
| Sep 30, 2016 | 1.27% |
| Jun 30, 2016 | -0.14% |
| Dec 31, 2015 | 0.00% |